Trump Secures Drug Pricing Deal with AstraZeneca for Affordable Prescriptions
Donald Trump strikes a deal with British drugmaker AstraZeneca for a “most-favored-nation” drug-pricing model, aiming to make prescription drugs more affordable.
Tech Giants Cease Displaying Political Ads in EU Following New Law
New EU law on political advertising pushes Google, Meta, and Microsoft to halt such ads in the EU, citing…
PennyWise: Personal Finance Tips, Travel Guides & Local Business News
Enable JavaScript to run PennyWise app for Personal Finance, Travel Tips, and the latest business news.
Economic Security Through Green Industrial Policy
The European Commission is updating its 2023 Economic Security Strategy amid global trade turbulence. The focus on economic security and trade negotiations may impact green technology firms.
Boost Longevity: High Aerobic Fitness Reduces Chronic Disease Risk
The Significant Role of Maintaining a High Cardiorespiratory Fitness Level in Midlife
One effective way to live…
Analysis: Trump’s ‘Most-Favored-Nation’ Drug Pricing Order May…
President Trump's executive order aims to lower drug prices for Americans. However, this article explains why it's…
France Eyed as Europe’s New ‘Bad Boy’: Could a Technocratic Government be the Solution?
Facing political turmoil, France is urged to consider a technocratic government, as political deadlock continues under Emmanuel Macron.
Legal Fights, Market Changes & Future of Drug Pricing Reform
In a webinar on drug pricing reform, experts discuss the industry's response to President Trump's executive order…
Company Poised to Expand in US Pharma Digital Ad Market, Predicted at $21.6B by…
Company poised to penetrate US digital pharma ad market, projected to hit $21.6B by 2026. OPRX Q2 shows promising…
New Orleans Council Candidate’s Campaign Advertisements May Violate Law
State Rep. Delisha Boyd, running for New Orleans City Council, is under scrutiny for potentially violating campaign finance laws by using campaign funds to promote her private real estate business.